Savior Lifetec Corporation (TPEX: 4167)

Market Cap	6.51B
Revenue (ttm)	1.26B
Net Income (ttm)	179.84M
Shares Out	317.40M
EPS (ttm)	0.58
PE Ratio	35.05
Forward PE	n/a
Dividend	0.09 (0.42%)
Ex-Dividend Date	Jul 12, 2024

Volume	549,203
Open	20.35
Previous Close	20.35
Day's Range	20.35 - 20.50
52-Week Range	18.10 - 27.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various products, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2023, Savior Lifetec's revenue was 1.05 billion, a decrease of -17.02% compared to the previous year's 1.27 billion. Earnings were 30.03 million, a decrease of -17.47%.